A new approach to bone marrow transplantation for sickle cell disease using targeted radiation.

A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation

NIH-funded research Beckman Research Institute/city of Hope · NIH-10869998

This study is exploring a new way to treat sickle cell disease using a special bone marrow transplant technique that carefully targets radiation to help the transplant work better while protecting important organs, and it's designed for patients looking for improved treatment options.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBeckman Research Institute/city of Hope NIH-funded
Lab location1 site (Duarte, United States)
Project IDNIH-10869998 on NIH RePORTER

What this research studies

This research investigates a novel method for treating sickle cell disease (SCD) through a specialized bone marrow transplantation technique that uses targeted marrow irradiation. The approach aims to minimize damage to vital organs while enhancing the effectiveness of the transplant. By utilizing advanced imaging technology, the researchers can precisely deliver radiation to the bone marrow, potentially improving patient outcomes and reducing the risk of complications. The study will involve preclinical models to better understand how this method can increase donor cell acceptance and improve treatment success.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with sickle cell disease who may benefit from bone marrow transplantation.

Not a fit: Patients who do not have sickle cell disease or those who are not eligible for bone marrow transplantation may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could provide a safer and more effective curative treatment option for patients with sickle cell disease.

How similar studies have performed: Other research has shown promise with similar targeted irradiation approaches, indicating potential for success in this novel application.

Where this research is happening

Duarte, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.